Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000311 · ClinicalTrials.gov registry record · Phase 3
Combining Behavioral Treatment With Agonist Maintenance - 1
A Phase 3 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 3
- Development phase
- 168
- Enrollment target
NCT00000311 is a Phase 3 study that has completed, run by Yale University. The registered enrollment target is 168 participants.
The verdict
NCT00000311, a Phase 3 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 168 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether the community reinforcement approach (CRA) plus contingency management (CM) is more effective overall than CRA only in reducing illicit opioid and cocaine use during agonist maintenance treatment and at 3 and 6 month follow-up after completion of study protocol, and to compare the efficacy of maintenance on buprenorphine to methadone when maintenance is combined with CRA only or CRA plus CM.
Interventions
- DRUG Buprenorphine
- DRUG methadone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 168 participants |
| Start Date | 1995-02 |
| Est. Completion | 1999-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000311
The ClinicalTrials.gov registry entry for NCT00000311 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 168 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buprenorphine is the first listed.
NCT00000311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00000311 about?
NCT00000311 is a clinical study titled "Combining Behavioral Treatment With Agonist Maintenance - 1". The purpose of this study is to evaluate whether the community reinforcement approach (CRA) plus contingency management (CM) is more effective overall than CRA only in reducing illicit opioid and cocaine use during agonist maintenance treatment and at 3 and 6 month follow-up after completion of stud...
What is the current status of trial NCT00000311?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 168 participants. The study started on 1995-02. Estimated completion is 1999-02.
What interventions are being tested in trial NCT00000311?
The interventions under investigation include: Buprenorphine (DRUG), methadone (DRUG).
Who is sponsoring clinical trial NCT00000311?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.